Compositions and methods comprising medium chain triglycerides for treatment of epilepsy

Patent metadata

Field	Value
Publication number	US-9789079-B2
Application number	US-201514960559-A
Country	US
Kind code	B2
Filing date	Dec 7, 2015
Priority date	Dec 8, 2014
Publication date	Oct 17, 2017
Grant date	Oct 17, 2017

Abstract

The invention provides compositions and methods for treatment of epilepsy in an animal. In one embodiment, a dietary regime suitable for enhancing the effect of an anti-epileptic drug (AED) in an animal can comprise a food composition comprising a medium chain triglyceride (MCT) and the AED, wherein the MCT is present in the food composition in an effective amount for enhancing the effect of the AED when the food composition and the AED are administered to the animal.

First claim

What is claimed is:

1. A method for enhancing the effect of an anti-epileptic drug (AED) in an animal comprising administering a food composition comprising a medium chain triglyceride (MCT) and a nitric oxide releasing compound in conjunction with an anti-epileptic drug (AED) to the animal, wherein the MCT is of Formula 1:

wherein the R′, R″, and R′″ esterified to the glycerol backbone are each independent fatty acids having 5-12 carbons; wherein the MCT is administered in an effective amount for enhancing the effect of the AED in the animal.

2. The method of claim 1 , wherein the animal is a companion animal.

3. The method of claim 1 , wherein the animal is a canine or a feline.

4. The method of claim 1 , wherein the AED is selected from the group consisting of acetazolamide, carbamazepine, chlorazepate, clobazam, clonazepam, diazepam, eslicarbazepine acetate, ethisyxunudem, ethosuximide, felbamate, gabapentin, imepitoin, keppra, lacosamide, lamotrigine, levetiracetam, methylphenobarbitone, nitrazepam, oxcarbazepine, perampanel, piracetam, phenobarbital, phenytoin, potassium bromide, pregabalin, primidone, retigabine, rufinamide, sodium bromide, sodium valproate, stiripentol, sulthiame, tiagabine, topiramate, valporic acid, vigabatrin, zonisamide, salts thereof, and mixtures thereof.

5. The method of claim 1 , wherein the food composition comprises from about 1% to about 15% of the MCT and the food composition is administered simultaneously with the AED.

6. The method of claim 1 , wherein the food composition is administered on an extended regular basis.

7. The method of claim 1 , wherein the food composition is administered to the animal on a daily basis.

8. The method of claim 1 , wherein the administration results in a reduction in seizure frequency of the animal by at least 50% compared to administration of the AED with a food composition not containing the MCT.

Assignees

• Nestec Sa
• Nestec Sa

Inventors

• Pan Yuanlong
• Zanghi Brian Michael
• Bouthegourd Jean-Christophe

Classifications

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P25/08

  Antiepileptics; Anticonvulsants · CPC title

• A61K31/4015

  having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide · CPC title

• A61K31/5377

  not condensed and containing further heterocyclic rings, e.g. timolol · CPC title

• A61K33/00

  Medicinal preparations containing inorganic active ingredients · CPC title